文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺切除术后生化失败时mpMRI与PSMA PET/CT检测局部复发的对照研究

Detection of local recurrent disease at biochemical failure after prostatectomy by multiparametric MRI versus PSMA PET/CT within a controlled study.
PubMed 文献 · Radiother Oncol · 2025-11-14

该前瞻性II期研究纳入107例根治性前列腺切除术后生化失败(PSA>0.2且<2 ng/ml)患者,同时行mpMRI和PSMA PET/CT检测前列腺窝病灶。68例(63.5%)发现至少一个病灶,其中仅mpMRI检出24例(35.3%),仅PSMA PET/CT检出4例(5.9%),两者均检出40例(58.8%)。两种影像学方法一致性不足(Cohen's k=0.49),mpMRI检出局部病灶数显著多于PSMA PET/CT(p<0.001)。

要点

  • mpMRI检出局部病灶显著多于PSMA PET/CT(p<0.001)。
  • 两种影像学方法一致性不足(Cohen's k=0.49)。
  • 不一致配对占41.2%(28/68),高于预期。

核心结论

  • mpMRI与PSMA PET/CT在前列腺切除术后生化失败时检测局部复发病灶的一致性不足,mpMRI检出局部病灶数显著多于PSMA PET/CT,对预后和治疗均有影响。

研究设计与样本

  • 前瞻性II期研究,纳入单中心根治性前列腺切除术后(pT2-3pN0-x)生化失败(PSA>0.2 ng/ml且<2 ng/ml)并转诊行挽救性放疗的患者,所有患者均行mpMRI和PSMA PET/CT。
  • 共连续纳入107例患者, accrual时间为2022年9月至2024年9月,再分期时平均PSA为0.53 ng/ml。

主要发现

  • 68例(63.5%,95%CI:54.1-72.1%)在前列腺窝发现至少一个病灶。
  • 仅mpMRI检出24例(35.3%),仅PSMA PET/CT检出4例(5.9%),两者均检出40例(58.8%)。
  • 不一致配对为28/68(41.2%),高于预期且差异显著(p<0.001)。
  • 两种影像学方法间Cohen's k一致性为0.49(p<0.001)。

关键数值与推荐

  • 生化失败定义为PSA>0.2 ng/ml但<2 ng/ml。
  • 终点为前列腺窝内离散病灶的检出。
  • 阳性检出比例比较采用McNemar检验,一致性采用Cohen's k检验。

临床怎么用

  • 在前列腺切除术后生化失败且PSA处于0.2-2 ng/ml时,mpMRI可能检出更多前列腺窝局部病灶,解读PSMA PET/CT阴性结果时需结合mpMRI。
  • 两种影像学方法一致性不足,治疗决策(如挽救性放疗靶区)应考虑影像学差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Whether the performance in detecting local recurrent lesions is similar between multiparametric MRI (mpMRI) and PSMA PET/CT at biochemical failure after radical prostatectomy is controversial and the present study was done to elucidate this point within a prospective phase II on extreme hypofractionation for prostate cancer. MATERIALS AND METHODS: Patients referred for salvage radiotherapy after surgery for pT2-3pN0-x prostate cancer at a single Institution were considered. PSA at biochemical failure had to be higher than 0.2 ng/ml but lower than 2 ng/ml. Patients underwent both mpMRI of the pelvis and PSMA PET/CT. The detection of a discrete lesion within the prostatic fossa was considered the endpoint of the present study. The proportion of patients with positive findings in the two paired groups was compared with the McNemar test, while agreement with Cohen's k test. RESULTS: 107 consecutive patients were accrued from September 2022 to September 2024. The mean PSA value at restaging was 0.53 ng/ml. Overall, 68 patients (63.5 %, 95 %CI: 54.1-72.1 %) were found to harbor at least one lesion in the prostatic fossa; 24 (35.3 %), 4 (5.9 %) and 40 (58.8 %) were detected only by mpMRI, only by PSMA PET/CT and by both tests, respectively. The percentage of discordant pairs was higher than expected (28/68, 41.2 %) and significantly different (p < 0.001). The Cohen's agreement between the two imaging modalities was 0.49, p < 0.001. CONCLUSION: mpMRI and PSMA PET/CT show inadequate agreement with the former detecting a significantly higher number of local lesions than the latter with both prognostic and therapeutic implications.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Sanguineti G, Goanta L, Bottero M, et al. Detection of local recurrent disease at biochemical failure after prostatectomy by multiparametric MRI versus PSMA PET/CT within a controlled study. Radiother Oncol. 2025. PMID: 41242406. doi:10.1016/j.radonc.2025.111287

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。